The gaming company THQ Nordic AB (publ) has acquired the shares of Experiment 101 AB, a Swedish independent game developer, currently developing the game Biomutant. The acquisition includes the development studio and all intellectual property rights to Biomutant.  The total consideration paid for all shares is SEK 75.3 million. Part of the consideration is paid by issuance of new THQ Nordic B shares.

THQ Nordic acquires, develops and publishes PC and console games. The company has a wide catalogue of 295 games, including 86 owned franchises.

THQ Nordic shares are publicly listed on Nasdaq First North Stockholm.

Baker McKenzie’s team consisted of responsible partners Anna Orlander and Joakim Falkner and  associates Erik Holmgren, Alexandra Persson, Ian Gulam, Johan Zetterström and Ida Cederborg.

Explore Our Newsroom